Vasmatzis G - Search Results

1

Reduction of the nonspecific animal toxicity of anti-Tac(Fv)-PE38 by mutations in the framework regions of the Fv which lower the isoelectric point.

Onda M, Kreitman RJ, Vasmatzis G, Lee B, Pastan I. Onda M, et al. Among authors: vasmatzis g. J Immunol. 1999 Dec 1;163(11):6072-7. J Immunol. 1999. PMID: 10570296

2

Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis.

Gagnon MF, Penheiter AR, Harris F, Sadeghian D, Johnson SH, Karagouga G, McCune A, Zepeda-Mendoza C, Greipp PT, Xu X, Ketterling RP, McPhail ED, King RL, Peterson JF, Vasmatzis G, Baughn LB. Gagnon MF, et al. Among authors: vasmatzis g. Blood Cancer J. 2023 Dec 19;13(1):190. doi: 10.1038/s41408-023-00967-8. Blood Cancer J. 2023. PMID: 38114462 Free PMC article. No abstract available.

3

Dynamics and survival associations of T cell receptor clusters in patients with pleural mesothelioma treated with immunotherapy.

Desai AP, Kosari F, Disselhorst M, Yin J, Agahi A, Peikert T, Udell J, Johnson SH, Smadbeck J, Murphy S, Karagouga G, McCune A, Schaefer-Klein J, Borad MJ, Cheville J, Vasmatzis G, Baas P, Mansfield A. Desai AP, et al. Among authors: vasmatzis g. J Immunother Cancer. 2023 Jun;11(6):e006035. doi: 10.1136/jitc-2022-006035. J Immunother Cancer. 2023. PMID: 37279993 Free PMC article. Clinical Trial.

4

Hydrophobicity identifies false positives and false negatives in peptide-MHC binding.

Solanki A, Riedel M, Cornette J, Udell J, Vasmatzis G. Solanki A, et al. Among authors: vasmatzis g. Front Oncol. 2022 Nov 7;12:1034810. doi: 10.3389/fonc.2022.1034810. eCollection 2022. Front Oncol. 2022. PMID: 36419888 Free PMC article.

5

Subtype of SCLC Is an Intrinsic and Persistent Feature Through Systemic Treatment.

Lo YC, Rivera-Concepcion J, Vasmatzis G, Aubry MC, Leventakos K. Lo YC, et al. Among authors: vasmatzis g. JTO Clin Res Rep. 2023 Aug 16;4(9):100561. doi: 10.1016/j.jtocrr.2023.100561. eCollection 2023 Sep. JTO Clin Res Rep. 2023. PMID: 37731627 Free PMC article.

6

Complex balanced intrachromosomal rearrangement involving PITX2 identified as a cause of Axenfeld-Rieger Syndrome.

Farris J, Khanna C, Smadbeck JB, Johnson SH, Bothun E, Kaplan T, Hoffman F, Polonis K, Oliver G, Reis LM, Semina EV, Rust L, Hoppman NL, Vasmatzis G, Marcou CA, Schimmenti LA, Klee EW. Farris J, et al. Among authors: vasmatzis g. Am J Med Genet A. 2024 May;194(5):e63542. doi: 10.1002/ajmg.a.63542. Epub 2024 Jan 17. Am J Med Genet A. 2024. PMID: 38234180

7

Stabilization of a recombinant Fv fragment by base-loop interconnection and V(H)-V(L) permutation.

Brinkmann U, Di Carlo A, Vasmatzis G, Kurochkina N, Beers R, Lee B, Pastan I. Brinkmann U, et al. Among authors: vasmatzis g. J Mol Biol. 1997 Apr 25;268(1):107-17. doi: 10.1006/jmbi.1996.0850. J Mol Biol. 1997. PMID: 9149145

8

Stabilization of protein structures.

Lee B, Vasmatzis G. Lee B, et al. Among authors: vasmatzis g. Curr Opin Biotechnol. 1997 Aug;8(4):423-8. doi: 10.1016/s0958-1669(97)80063-8. Curr Opin Biotechnol. 1997. PMID: 9265720 Review.

9

Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis.

Vasmatzis G, Essand M, Brinkmann U, Lee B, Pastan I. Vasmatzis G, et al. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):300-4. doi: 10.1073/pnas.95.1.300. Proc Natl Acad Sci U S A. 1998. PMID: 9419370 Free PMC article.

10

Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond.

Almog O, Benhar I, Vasmatzis G, Tordova M, Lee B, Pastan I, Gilliland GL. Almog O, et al. Among authors: vasmatzis g. Proteins. 1998 May 1;31(2):128-38. Proteins. 1998. PMID: 9593187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page